JP2001000531A - Medical device with lubricity - Google Patents
Medical device with lubricityInfo
- Publication number
- JP2001000531A JP2001000531A JP11208063A JP20806399A JP2001000531A JP 2001000531 A JP2001000531 A JP 2001000531A JP 11208063 A JP11208063 A JP 11208063A JP 20806399 A JP20806399 A JP 20806399A JP 2001000531 A JP2001000531 A JP 2001000531A
- Authority
- JP
- Japan
- Prior art keywords
- nitrogen atom
- medical device
- tertiary nitrogen
- solution
- polyether
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 claims abstract description 28
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 21
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 19
- 239000004814 polyurethane Substances 0.000 claims abstract description 18
- 229920002635 polyurethane Polymers 0.000 claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 230000001050 lubricating effect Effects 0.000 claims abstract description 7
- 239000000758 substrate Substances 0.000 claims abstract description 7
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 4
- 229920000570 polyether Polymers 0.000 claims description 4
- -1 nitrogen-containing compound Chemical group 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- 210000001124 body fluid Anatomy 0.000 abstract description 2
- 239000010839 body fluid Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 24
- 239000000243 solution Substances 0.000 description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 8
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 8
- 230000003068 static effect Effects 0.000 description 8
- 229920006163 vinyl copolymer Polymers 0.000 description 7
- IWTYTFSSTWXZFU-UHFFFAOYSA-N 3-chloroprop-1-enylbenzene Chemical group ClCC=CC1=CC=CC=C1 IWTYTFSSTWXZFU-UHFFFAOYSA-N 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 238000003618 dip coating Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920003226 polyurethane urea Polymers 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000001302 tertiary amino group Chemical group 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 229910001080 W alloy Inorganic materials 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012975 dibutyltin dilaurate Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 239000002783 friction material Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229940028444 muse Drugs 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000909 polytetrahydrofuran Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
Abstract
(57)【要約】
【課題】 人体に挿入などして、生体組織、体液、血液
と接触することのある医療用具で、潤滑性を有するもの
をを提案するにある。
【解決手段】 表面が潤滑性を有する親水性材料を第3
級の窒素原子を含有する化合物および/またはその混合
物を用いて基材に固定する。なお、第3級の窒素原子を
含有する化合物をポリエーテル型ポリウレタンとしてよ
く、更に、ポリエーテル型ポリウレタンの主鎖中に第3
級の窒素原子が存在していることを選択できる。
(57) [Summary] [PROBLEMS] To provide a medical device having lubricating properties which may be brought into contact with a living tissue, a body fluid, or blood by being inserted into a human body or the like. SOLUTION: A hydrophilic material having a lubricating surface is made of a third material.
It is fixed to a substrate by using a compound containing a grade nitrogen atom and / or a mixture thereof. The compound containing a tertiary nitrogen atom may be a polyether-type polyurethane, and further, a tertiary nitrogen atom may have a tertiary nitrogen atom in the main chain of the polyether-type polyurethane.
It can be chosen that a first-class nitrogen atom is present.
Description
【0001】[0001]
【発明の属する技術分野】 本発明は、人体に挿入など
して、生体組織、体液、血液と接触することのある医療
用具の改良に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an improvement of a medical device that may be brought into contact with a living tissue, a body fluid, or blood when inserted into a human body.
【0002】[0002]
【従来の技術】 医療用具には、血管、気管、尿道など
人体の組織や体腔に挿入するもの、またその挿入手技に
併用されるガイドワイヤー、スタイレット等があるが、
その挿入により異物反応を惹起したり、該医療用具に血
栓の付着や組織接着を生ずる問題がある。そこで、医療
用具の挿入時における医療上のトラブルを回避するた
め、組織や粘膜との接触による損傷を低減することが、
該医療用具に要請されるが、その方策として、該医療用
具に低摩擦材料を用いる必要のあることが指摘されてき
た。そのため、例えばフッ素樹脂や高密度ポリエチレン
などが使用されている。この外、医療用具に潤滑性を付
与するため、その挿入時に医療用具基材表面にグリセリ
ン、オリーブオイル或いはシリコーンオイルなどを塗布
する方法がとられている。しかし、これではその効果の
持続性に乏しいという欠点があるのみならず、これらの
オイルは低い毒性を示し、人体組織に対する有害事象が
あったとする報告例も存するので、安全性の見地からの
問題もある。また、該基材の表面を粗し、接触面積を減
少させることにより、摩擦力を減らす手段もとられる
が、簡便な手段ではあるものの、医療上満足できる性能
を具備させるには、ほど遠かった。近年、医療用具表面
に親水性材料を用いた層を形成させ、湿潤時に低摩擦性
を付与する手段が研究されている。例えば、イソシアネ
ートを用いたポリビニルピロリドンの固定(米国特許第
4100309号、特公昭59−19582)、医療用
具表面に未反応のイソシアネート基を形成させ、この基
と共有結合可能な親水性重合体とを反応させる方法(特
開昭59−81341)、表面にイソシアネート、ポリ
オール、ポリ酸化エチレンのコート液を塗布し反応させ
た、ポリ酸化エチレンが会合したポリウレタンによる方
法(特開平4−227671)、活性水素を有する化合
物をポリイソシアネート化合物を介して結合させる方法
(特公平1−55023)、基材表面上の反応性官能基
と無水マレイン酸系高分子とを共有結合させる方法(特
公平1−33181)、ポリウレタン表面にコーティン
グ操作によって官能基を導入し、さらにコーティング操
作によって親水性ポリマーを表面に固定化する方法(W
D90/01344号)、紫外線グラフト法による耐剥
離性が付与された潤滑性材料の形成方法(特開平9−3
13594)などがある。しかしながら、これらの方法
で安定した潤滑性を付与するには、いずれも多くの工程
と時間を要する欠点があった。また、比較的簡便な方法
によって作成された潤滑性材料は、その効果が一時的な
ものに過ぎないものが殆どであり、医療の実際において
満足できるものは皆無である。特にシリコーンポリマー
のような反応性の低い疎水性材料は、この傾向が顕著で
あった。2. Description of the Related Art Medical devices include those that are inserted into tissues or body cavities of the human body, such as blood vessels, trachea, and urethra, and guidewires and stylets that are used together with the insertion procedure.
There is a problem in that the insertion causes a foreign body reaction or causes a thrombus to adhere to the medical device or tissue adhesion. Therefore, in order to avoid medical problems when inserting a medical device, it is necessary to reduce damage due to contact with tissues and mucous membranes,
It has been pointed out that it is necessary to use a low friction material for the medical device as a measure for the medical device. Therefore, for example, fluororesin or high-density polyethylene is used. In addition, in order to impart lubricity to the medical device, a method of applying glycerin, olive oil, silicone oil, or the like to the surface of the medical device substrate at the time of insertion is used. However, this not only has the disadvantage of poor sustainability of its effects, but also has a low toxicity, and there are some reports that there were adverse events to human tissues. There is also. In addition, by roughening the surface of the base material and reducing the contact area, a means for reducing the frictional force can be taken. However, although it is a simple means, it is far from providing medically satisfactory performance. . In recent years, means for forming a layer using a hydrophilic material on the surface of a medical device to impart low friction when wet have been studied. For example, immobilization of polyvinylpyrrolidone using isocyanate (US Pat. No. 4,100,309, Japanese Patent Publication No. 59-19582), formation of an unreacted isocyanate group on the surface of a medical device, and formation of a hydrophilic polymer capable of covalently bonding to this group. Reaction method (JP-A-59-81341), a method using a polyurethane in which a coating solution of isocyanate, polyol and poly (ethylene oxide) is applied and reacted on the surface (JP-A-4-227671), active hydrogen (Japanese Patent Publication No. 1-55023), a method of covalently bonding a reactive functional group on the substrate surface to a maleic anhydride-based polymer (Japanese Patent Publication No. 1-31811). , Functional groups are introduced on the polyurethane surface by coating A method for immobilizing on the surface of the hydrophilic polymer by work (W
D90 / 01344), and a method for forming a lubricating material to which peeling resistance has been imparted by an ultraviolet grafting method (Japanese Patent Application Laid-Open No. 9-3)
13594). However, in order to impart stable lubricating properties by these methods, there is a disadvantage that many steps and time are required. In addition, most lubricating materials produced by a relatively simple method have only temporary effects, and none are satisfactory in medical practice. In particular, this tendency was remarkable for hydrophobic materials having low reactivity such as silicone polymers.
【0003】[0003]
【発明が解決しようとする課題】 本発明の目的は、潤
滑性成分である親水性材料を医療用具基材表面に反応性
官能基の導入後、複雑な前処理を施すことなく、簡便な
手段である、該基材に直接塗布することにより高度な接
着性を付与し、従って潤滑性が一時的なものではなく、
十分医療目的に適う効果を挙げることができる医療用具
を提供することにある。SUMMARY OF THE INVENTION An object of the present invention is to provide a simple method without introducing a complicated pretreatment after introducing a reactive functional group onto a surface of a medical device substrate by using a hydrophilic material as a lubricating component. Is applied directly to the substrate to provide a high degree of adhesion, and thus the lubricity is not temporary,
An object of the present invention is to provide a medical device capable of sufficiently providing an effect suitable for a medical purpose.
【0004】[0004]
【課題を解決するための技術手段】 上記課題を解決す
るため、鋭意研究を継続したところ、第3級の窒素原子
を含む化合物を用いることにより、従来の提案と比較し
て、工程数が少ない簡便な方法により、抗凝血性と潤滑
性を併有する医療用具を提案できることがわかった。該
医療用具は、血管系に用いるカテーテル、ガイドワイヤ
ー、スタイレット、シースや、導尿用カテーテルのよう
に尿道から挿入する手技を伴うものなど、挿入時に組織
や血液と接触する医療用具において、その効果が著しい
が、その他長尺状のものや複合的手技に用いるものにも
有効である。また、基材についても、金属例えばステン
レス、ニッケル・チタン合金、タングステン合金でよ
く、ポリマーとしては、ポリオレフィン、ポリ塩化ビニ
ル、ポリスチレン、ポリアクリレート、ポリアクリロニ
トリル、ポリウレタン、ポリアミド、ポリエステル、ポ
リカーボネート、セルロース、シリコーンなどでよく、
さらに、セラミックなど単体や複合化したものでもよ
い。次に医療用具の基材に潤滑性を付与する手段をより
詳細に述べると、第1に、基材上に第3級の窒素原子を
含有する化合物および/または混合物層を形成して基材
と強く接着させ、さらにこの第3級の窒素原子と親水性
材料との両方に反応性のある官能基を単一化合物中に2
個以上有する化合物層を介在させ、第3級の窒素原子と
親水性材料を結合させる方法、第2に、基材上に第3級
の窒素原子を含有する化合物および/または混合物と少
なくとも第3級の窒素原子と反応性もしくは混合性を有
する物質層を形成させ、該層上に第3級の窒素原子と反
応性を有する親水性材料層を形成する方法、第3に、基
材上に第3級の窒素原子を含有する化合物および/また
は混合物と親水性材料とを混合した層を形成する方法が
ある。このように基材表面に前記各層を形成する手段と
しては、ディッピングや吹き付けなど種々の方法があ
り、特に限定されない。上記第3級窒素原子を含む化合
物および/または混合物としては、種々あるが、例えば
特許第2663186号や特許第2615698号に示
されたような第3級アミノ基含有ジオールを使用して作
製されたポリウレタンおよびポリウレタンウレアが使用
できるが、もとより、これに限定されず、第3級の窒素
原子を含有していれば、その他のものでよい。好適に
は、主鎖に第3級の窒素原子構造を含むポリエーテル型
ポリウレタンである。前記第3級の窒素原子と反応性の
ある基としては、一般的に染色性の付与や接着性の改善
等に使用されているようにハロゲン化アルキルや硫酸エ
ステルが広く知られているが、これに限定されない。し
かし、より好適には、クロロメチルスチレン構造を有す
るものや、イソシアネート基或いはエポキシ基を有する
化合物を使用することが望ましい。潤滑性を有する親水
性材料としては、種々のものが使用できる。例えば、ア
クリルアミドやその誘導体よりなるポリマー、ポリビニ
ルピロリドン、ポリビニルアルコール、ポリエチレング
リコール鎖を有する重合体、各種糖や多糖類、セルロー
スやその誘導体、リン脂質、無水マレイン酸系重合体な
どが使用できる。が最も好適には、ポリビニルピロリド
ンおよびクロロメチルスチレン構造を有するビニル共重
合体や無水マレイン酸系共重合体が使用できる。前記第
3級の窒素原子と親水性材料との混合層を形成させる場
合、それぞれの材料を溶解可能もしくは混合可能な溶媒
を用いることができる材料であれば、いずれでもよい
が、好適には、クロロメチルスチレン構造および/また
は第4級アンモニウム塩および/またはアクリルアミド
および/またはポリオキシエチレン構造を有するビニル
共重合体、さらに無水マレイン酸共重合体が使用でき
る。[Technical Means for Solving the Problems] In order to solve the above-mentioned problems, the present inventors have conducted intensive studies and found that the use of a compound containing a tertiary nitrogen atom reduces the number of steps as compared with the conventional proposal. It was found that a medical device having both anticoagulant properties and lubricity can be proposed by a simple method. The medical device is a catheter used for a vascular system, a guide wire, a stylet, a sheath, and a medical device that comes into contact with tissue or blood at the time of insertion, such as a device involving a procedure of inserting from the urethra such as a urinary catheter. Although the effect is remarkable, it is also effective for those having a long shape and those used for complex procedures. Also, the base material may be a metal such as stainless steel, nickel-titanium alloy, tungsten alloy, and the polymer may be polyolefin, polyvinyl chloride, polystyrene, polyacrylate, polyacrylonitrile, polyurethane, polyamide, polyester, polycarbonate, cellulose, silicone. Etc.
Further, it may be a single material such as ceramic or a composite material. Next, the means for imparting lubricity to the base material of the medical device will be described in more detail. First, a compound and / or mixture layer containing a tertiary nitrogen atom is formed on the base material to form a base material. And a functional group reactive with both the tertiary nitrogen atom and the hydrophilic material in a single compound.
A method of bonding a tertiary nitrogen atom to a hydrophilic material through a compound layer having at least three tertiary nitrogen atoms and / or a mixture containing a tertiary nitrogen atom-containing compound and / or a mixture on a substrate. A method of forming a substance layer having a reactivity or a mixture property with a grade nitrogen atom, and forming a hydrophilic material layer having a reactivity with a tertiary nitrogen atom on the layer. There is a method of forming a layer in which a compound and / or mixture containing a tertiary nitrogen atom and a hydrophilic material are mixed. Means for forming each of the above-mentioned layers on the surface of the base material include various methods such as dipping and spraying, and is not particularly limited. There are various compounds and / or mixtures containing the tertiary nitrogen atom. For example, the tertiary amino group-containing diol is prepared using a tertiary amino group-containing diol as disclosed in Japanese Patent No. 2663186 or Japanese Patent No. 2615698. Polyurethane and polyurethane urea can be used, but are not limited to these, and other materials may be used as long as they contain a tertiary nitrogen atom. Preferably, it is a polyether-type polyurethane containing a tertiary nitrogen atom structure in the main chain. As the tertiary nitrogen-reactive group, alkyl halides and sulfates are widely known as generally used for imparting dyeability and improving adhesiveness. It is not limited to this. However, it is more preferable to use a compound having a chloromethylstyrene structure or a compound having an isocyanate group or an epoxy group. Various materials can be used as the hydrophilic material having lubricity. For example, a polymer comprising acrylamide or a derivative thereof, polyvinylpyrrolidone, polyvinyl alcohol, a polymer having a polyethylene glycol chain, various sugars and polysaccharides, cellulose or a derivative thereof, a phospholipid, a maleic anhydride polymer, and the like can be used. Most preferably, a vinyl copolymer or a maleic anhydride copolymer having a polyvinylpyrrolidone and chloromethylstyrene structure can be used. When forming a mixed layer of the tertiary nitrogen atom and the hydrophilic material, any material may be used as long as a solvent capable of dissolving or mixing each material can be used. A vinyl copolymer having a chloromethylstyrene structure and / or a quaternary ammonium salt and / or acrylamide and / or a polyoxyethylene structure, and further a maleic anhydride copolymer can be used.
【0005】[0005]
【発明の実施の形態】 本発明に係る医療用具につい
て、上記のとおり詳細に説明したので、以下にはその例
として、第3級の窒素原子を含有するポリウレタンの作
製例およびクロロメチルスチレン構造を含有したビニル
共重合体の作製例について述べるが、既に詳細に説明し
たとおり、これに限定されるものではないこと勿論であ
る。BEST MODE FOR CARRYING OUT THE INVENTION The medical device according to the present invention has been described in detail as described above. Hereinafter, as an example, a production example of a tertiary nitrogen-containing polyurethane and a chloromethylstyrene structure will be described. A production example of the contained vinyl copolymer will be described, but it is needless to say that the present invention is not limited to this as already described in detail.
【0006】まず、第3級の窒素原子を含むポリウレタ
ンの作製例(以下「作製例1」として引用する。)であ
るが、例えば、1000mLの4口セパラブルフラスコ
に4,4’−ジフェニルメタンジイソシアネート41、
25gとジオキサン95mLを加え、攪拌下に60℃に
加熱する。これに数平均分子量1010のポリテトラメ
チレンエーテルグリコール55、55gを110mLの
ジオキサンに溶解させた溶液を加え、さらに触媒として
5mLのジオキサンに溶解させたジラウリル酸ジブチル
スズ0、0546gを加え、2時間攪拌する。この反応
液中にさらに425mLのジオキサンを追加し、さらに
N−メチルジエタノールアミン9、82gおよび1,4
−ブタンジオール2、48gを95mLのジオキサンに
溶解させた液を30分間にわたって滴下した後、60〜
65℃で4時間反応させる。その後、大量の蒸留水中に
該反応液を加え、ポリマーを沈殿させる。この沈殿物を
水・メタノールで洗浄後、60℃で乾燥させ、第3級の
窒素原子を主鎖中に含有するポリウレタンを得る。First, an example of preparing a tertiary nitrogen-containing polyurethane (hereinafter referred to as "Preparation Example 1") is described. For example, a 4,4-diphenylmethane diisocyanate is placed in a 1000 mL four-neck separable flask. 41,
25 g and 95 mL of dioxane are added and heated to 60 ° C. with stirring. A solution prepared by dissolving 55 g of polytetramethylene ether glycol having a number average molecular weight of 1010 in 55 mL of dioxane was added to the solution, and 0,546 g of dibutyltin dilaurate dissolved in 5 mL of dioxane was added as a catalyst, followed by stirring for 2 hours. . An additional 425 mL of dioxane was added to the reaction mixture, and N-methyldiethanolamine 9, 82 g and 1,4
-A solution prepared by dissolving 2,48 g of butanediol in 95 mL of dioxane was added dropwise over 30 minutes,
React at 65 ° C for 4 hours. Thereafter, the reaction solution is added to a large amount of distilled water to precipitate the polymer. The precipitate is washed with water / methanol and dried at 60 ° C. to obtain a polyurethane containing a tertiary nitrogen atom in the main chain.
【0007】次に、クロロメチルスチレン構造を含有す
るビニル共重合体の作製例(以下「作製例2」として引
用する。)であるが、三ツ口フラスコ中に5、82gの
ジメチルアミノエチルメタクリレート4級化合物、2
3、81gのメトキシポリエチレングリコールメタクリ
レート、0、61gのクロロメチルスチレン、さらに重
合開始剤として0、1312gの2,2’−アゾビスイ
ソブチロニトリルを加えさらに、75mLのエタノール
を加える。この反応系中を窒素雰囲気下において60℃
で6時間反応させた後、70℃で15時間反応させる。
その後、ジエチルエーテルで再沈精製を行った後、60
℃で乾燥させ、わずかに黄色がかった飴状のビニル共重
合体を得る。Next, an example of the preparation of a vinyl copolymer having a chloromethylstyrene structure (hereinafter referred to as "Preparation Example 2") will be described. In a three-necked flask, 5,82 g of dimethylaminoethyl methacrylate quaternary is placed. Compound, 2
3,81 g of methoxypolyethylene glycol methacrylate, 0.61 g of chloromethylstyrene, and 0.11312 g of 2,2′-azobisisobutyronitrile as a polymerization initiator are added, and 75 mL of ethanol is further added. The temperature of the reaction system is set to 60 ° C. in a nitrogen atmosphere.
And then react at 70 ° C. for 15 hours.
Then, after reprecipitation purification with diethyl ether,
Dry at ℃ to obtain a slightly yellowish candy-like vinyl copolymer.
【0008】そこで、作製例1および作製例2を参酌し
つつ、本発明の実施例を順次説明するが、上記のとお
り、もとよりこれに限定されるものではない。なお、潤
滑性の評価にあたり、新東科学社製のポータブル摩擦計
HEIDONトライボギアミューズ94iを使用して静
摩擦係数を測定した。[0008] Then, the embodiments of the present invention will be sequentially described with reference to Production Example 1 and Production Example 2, but as described above, the invention is not limited thereto. In evaluating the lubricity, the static friction coefficient was measured using a portable friction meter HEIDON Tribogear Muse 94i manufactured by Shinto Kagaku.
【0009】[0009]
【実施例1】 作製例1で得られたポリウレタンの5%
テトラヒドロフラン溶液を用いて、ウレタンシート(ペ
レセン2363 80AE)にディップコートした後、
室温で16時間乾燥させた。その後、1%4,4’−ジ
フェニルメタンジイソシアネートのメチルエチルケトン
溶液でディップコートし、さらに室温で16時間乾燥さ
せた後、5%ポリビニルピロリドンのクロロホルム溶液
に浸せきし、室温で16時間乾燥させた後、100℃で
1時間熱処理を行った。これを生理食塩液に侵せきし、
静摩擦係数を測定したところ、0、05以下であった。
そこで、なお1ケ月生理食塩液に侵せきして計測した
が、静摩擦係数の低下は認められなかった。Example 1 5% of the polyurethane obtained in Production Example 1
After dip coating a urethane sheet (Pelecene 2363 80AE) using a tetrahydrofuran solution,
Dry at room temperature for 16 hours. Thereafter, dip coating was performed with a 1% solution of 4,4′-diphenylmethane diisocyanate in methyl ethyl ketone, followed by drying at room temperature for 16 hours. Heat treatment was performed at 1 ° C. for 1 hour. We invade this into physiological saline,
When the coefficient of static friction was measured, it was 0,05 or less.
Then, the measurement was carried out by immersion in physiological saline for one month, but no decrease in the coefficient of static friction was observed.
【0010】[0010]
【実施例2】 実施例1における4,4’−ジフェニル
メタンジイソシアネートに代えて、10%グリセロール
ポリグリシジルエーテル水溶液を用い、その余の手順を
同一にしたところ、同様の結果を得た。Example 2 A 10% glycerol aqueous solution of polyglycidyl ether was used in place of 4,4′-diphenylmethane diisocyanate in Example 1, and the other procedures were the same. Similar results were obtained.
【0011】[0011]
【実施例3】 実施例1におけるポリビニルピロリドン
に代えて作製例2で得られたビニル共重合体の5%テト
ラヒドロフラン溶液を用い、その余の手順を同一にした
ところ、同様の結果を得た。Example 3 A 5% tetrahydrofuran solution of the vinyl copolymer obtained in Production Example 2 was used in place of polyvinylpyrrolidone in Example 1, and the other procedures were the same. Similar results were obtained.
【0012】[0012]
【実施例4】 作製例1で得られた第3級の窒素原子を
含むポリエーテル型ポリウレタンの5%テトラヒドロフ
ラン溶液で基材をコーティングし、作製例2で得られた
ビニル共重合体の5%テトラヒドロフラン溶液でコート
し、110℃で3時間熱処理したところ、静摩擦係数は
0、05以下となり、十分な潤滑性を示した。Example 4 A base material was coated with a 5% tetrahydrofuran solution of the tertiary nitrogen-containing polyether-type polyurethane obtained in Preparation Example 1, and 5% of the vinyl copolymer obtained in Preparation Example 2 When coated with a tetrahydrofuran solution and heat-treated at 110 ° C. for 3 hours, the coefficient of static friction was 0.05 or less, indicating sufficient lubricity.
【0013】[0013]
【実施例5】 シリコーンシートに作製例1で得たポリ
エーテル型ポリウレタン0、3gと25%シリコーン溶
液を2、8g、テトラヒドロフラン溶液を16gを加え
て作製したコート液でコーティングした。その後ただち
に5%の作製例1で得られたポリエーテル型ポリウレタ
ンのテトラヒドロフラン溶液でコーティングを行い、1
50℃で1時間乾燥させた。こうして作製した下地層
に、1%4,4’−ジフェニルメタンジイソシアネート
のメチルエチルケトン溶液をディップコートした。さら
に、3%ポリビニルピロリドンのクロロホルム溶液でコ
ートし、室温で数時間乾燥させた後、さらに60℃で3
時間乾燥させた。こうして作製したコート膜を蒸留水に
浸した後、静摩擦係数を測定したところ、0、05以下
であった。Example 5 A silicone sheet was coated with a coating solution prepared by adding 0 and 3 g of the polyether polyurethane obtained in Preparation Example 1, 2.8 g of a 25% silicone solution, and 16 g of a tetrahydrofuran solution. Immediately thereafter, coating was performed with a 5% solution of the polyether polyurethane obtained in Preparation Example 1 in tetrahydrofuran.
Dry at 50 ° C. for 1 hour. The underlayer thus prepared was dip-coated with a 1% solution of 4,4′-diphenylmethane diisocyanate in methyl ethyl ketone. Further, after coating with a chloroform solution of 3% polyvinylpyrrolidone and drying at room temperature for several hours,
Let dry for hours. After immersing the thus-prepared coat film in distilled water, the coefficient of static friction was measured.
【0014】[0014]
【実施例6】 実施例5におけるポリビニルピロリドン
に代えて、メチルビニルエーテル無水マレイン酸共重合
体のテトラヒドロフラン溶液を用い、その余の手順を同
一にした結果も同様であった。Example 6 The same result was obtained by using a tetrahydrofuran solution of a methyl vinyl ether / maleic anhydride copolymer instead of polyvinylpyrrolidone in Example 5, and using the same procedure.
【0015】[0015]
【実施例7】 図1は、実施例の一例を示すチューブの
部分拡大断面図である。すなわち、実施例5と同一の手
順により、16Frサイズの3mシリコーンチューブ
(1)の内腔(2)を処理してコート膜(3)を設け、
1、32mm(0、052inch)のステンレス製ス
プリングタイプのガイドワイヤーを通し10cm の筒
に巻き付けた状態で、ガイドワイヤーの両端を500m
m/minの速さで10cmの移動量で交互に引っ張っ
た。その結果、前記処理をしていない場合には全く引っ
張ることができなかったのに比し、この処理をした場合
は50回試みたが約0、98N(100gf)の引っ張
り抵抗は終始変化がなかった。Seventh Embodiment FIG. 1 is a partially enlarged sectional view of a tube showing an example of the embodiment. That is, according to the same procedure as in Example 5, the inner cavity (2) of the 3 Fr silicone tube (1) of 16 Fr size was treated to provide the coat film (3),
A stainless steel spring type guide wire of 1, 32 mm (0, 052 inch) is passed through and wound around a 10 cm tube, and both ends of the guide wire are 500 m.
It was alternately pulled at a speed of m / min with a moving amount of 10 cm. As a result, in contrast to the case where no pulling could be performed without the above treatment, no attempt was made with this treatment, but 50 attempts were made, but the tensile resistance of about 0, 98 N (100 gf) remained unchanged throughout. Was.
【0016】[0016]
【実施例8】 4gの25%シリコーン溶液、4gのエ
ポキシ含有スチレン共重合体、さらに1gの作製例1で
得たポリエーテル型ポリウレタンを含むテトラヒドロフ
ラン溶液を用いてシリコーンシートにコーティングを行
い、風乾後、150℃で1時間熱処理を施した。その
後、1%4,4’−ジフェニルメタンジイソシアネート
のメチルエチルケトン溶液をディップコートした。さら
に、3%ポリビニルピロリドンのクロロホルム溶液でコ
ートし、室温で数時間乾燥させた後、60℃で3時間乾
燥させた。このように作製したサンプルも静摩擦係数
は、0、05以下であった。Example 8 A silicone sheet was coated with 4 g of a 25% silicone solution, 4 g of an epoxy-containing styrene copolymer, and 1 g of a tetrahydrofuran solution containing the polyether-type polyurethane obtained in Preparation Example 1, and air-dried. At 150 ° C. for 1 hour. Thereafter, a 1% solution of 4,4′-diphenylmethane diisocyanate in methyl ethyl ketone was dip-coated. Further, it was coated with a chloroform solution of 3% polyvinylpyrrolidone, dried at room temperature for several hours, and then dried at 60 ° C. for 3 hours. The samples thus produced also had a static friction coefficient of 0.05 or less.
【0017】[0017]
【実施例9】 基材をナイロンとして、実施例8におけ
るポリビニルピロリドンに代えてメチルビニルエーテル
無水マレイン酸共重合体のテトラヒドロフラン溶液を用
いて、その余は同一の手順によった場合も同様な結果を
得た。Example 9 The same result was obtained when the same procedure was followed except that a nylon was used as the base material, and instead of polyvinylpyrrolidone in Example 8, a tetrahydrofuran solution of a methylvinyl ether maleic anhydride copolymer was used. Obtained.
【0018】[0018]
【実施例10】 作製例1により得たポリエーテル型ポ
リウレタンの5%テトラヒドロフラン溶液とメチルビニ
ルエーテル無水マレイン酸共重合体の5%テトラヒドロ
フラン溶液を3対7の割合で混合し作製したコート液で
ウレタンシートにコーティングを行い、乾燥させた。そ
の後、3%アンモニア水に1時間浸せきし、蒸留水で洗
浄したサンプルの静摩擦係数は0、05以下であった。
このサンプルを1ケ月間生理食塩液中に浸せきさせたも
のの静摩擦係数は該浸せき前と変化はなかった。Example 10 A urethane sheet was prepared using a coating liquid prepared by mixing a 5% tetrahydrofuran solution of the polyether polyurethane obtained in Preparation Example 1 and a 5% tetrahydrofuran solution of a methyl vinyl ether maleic anhydride copolymer in a ratio of 3: 7. Was coated and dried. Thereafter, the sample immersed in 3% aqueous ammonia for 1 hour and washed with distilled water had a coefficient of static friction of 0.05 or less.
Although this sample was immersed in a physiological saline solution for one month, the coefficient of static friction did not change from that before the immersion.
【0019】[0019]
【発明の効果】 本発明によれば、人の健康を維持し、
または健康を回復するために必要な手技を、人体組織、
血液等を傷害することなく行うことができ、十分な医療
効果をあげることのできる医療用具を、比較的簡便に得
ることを可能にし、かつ、該医療用具の優れた性能を長
期間保持てきるから、患者の費用負担を軽減する利点を
も併せ有する。According to the present invention, human health is maintained,
Or the techniques needed to restore health,
It is possible to obtain a medical device which can be performed without damaging blood or the like and which can provide a sufficient medical effect, relatively easily, and maintains excellent performance of the medical device for a long time. Therefore, it also has the advantage of reducing the cost burden on the patient.
【図1】 実施例の一例を示すチューブ部分拡大断面図FIG. 1 is a partially enlarged sectional view of a tube showing an example of an embodiment.
1・・チューブ 2・・内腔 3・・コート膜 1. Tube 2. Lumen 3. Coat film
───────────────────────────────────────────────────── フロントページの続き (72)発明者 吉田 栄子 神奈川県横浜市都筑区茅ヶ崎南2丁目5番 25号 (72)発明者 久保田 学 神奈川県横浜市都筑区茅ヶ崎南2丁目5番 25号 Fターム(参考) 4C081 AC06 AC08 BA03 BB05 CA021 CA031 CA041 CA062 CA081 CA091 CA161 CA201 CA211 CA212 CA231 CA271 CD021 CF111 CG03 CG05 DA03 DC03 DC04 DC05 DC14 EA06 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Eiko Yoshida 2-5-2-5 Chigasaki-minami, Tsuzuki-ku, Yokohama-shi, Kanagawa Prefecture (72) Inventor Manabu Kubota 2-5-25-2 Chigasaki-minami, Tsuzuki-ku, Yokohama-shi, Kanagawa F Terms (reference) 4C081 AC06 AC08 BA03 BB05 CA021 CA031 CA041 CA062 CA081 CA091 CA161 CA201 CA211 CA212 CA231 CA271 CD021 CF111 CG03 CG05 DA03 DC03 DC04 DC05 DC14 EA06
Claims (3)
級の窒素原子を含有する化合物および/またはその混合
物を用いて基材に固定したことを特徴とする医療用具A hydrophilic material having a lubricating surface is made of a third material.
Medical device characterized in that it is fixed to a substrate using a compound containing a nitrogen atom of a grade and / or a mixture thereof.
リエーテル型ポリウレタンであることを特徴とする請求
項1の医療用具2. The medical device according to claim 1, wherein the tertiary nitrogen-containing compound is a polyether-type polyurethane.
第3級の窒素原子が存在していることを特徴とする請求
項1および請求項2の医療用具3. The medical device according to claim 1, wherein a tertiary nitrogen atom is present in the main chain of the polyether type polyurethane.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20806399A JP3512355B2 (en) | 1999-06-17 | 1999-06-17 | Medical device with lubricity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20806399A JP3512355B2 (en) | 1999-06-17 | 1999-06-17 | Medical device with lubricity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001000531A true JP2001000531A (en) | 2001-01-09 |
| JP3512355B2 JP3512355B2 (en) | 2004-03-29 |
Family
ID=16550038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP20806399A Expired - Lifetime JP3512355B2 (en) | 1999-06-17 | 1999-06-17 | Medical device with lubricity |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3512355B2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009518479A (en) * | 2005-12-09 | 2009-05-07 | ディーエスエム アイピー アセッツ ビー.ブイ. | Hydrophilic coating containing polyelectrolyte |
| US8513320B2 (en) | 2007-02-28 | 2013-08-20 | Dsm Ip Assets B.V. | Hydrophilic coating |
| US8809411B2 (en) | 2007-02-28 | 2014-08-19 | Dsm Ip Assets B.V. | Hydrophilic coating |
| US8828546B2 (en) | 2006-09-13 | 2014-09-09 | Dsm Ip Assets B.V. | Coated medical device |
| US8957125B2 (en) | 2010-06-16 | 2015-02-17 | Dsm Ip Assets B.V. | Coating formulation for preparing a hydrophilic coating |
| US9737637B2 (en) | 2004-11-29 | 2017-08-22 | Dsm Ip Assets B.V. | Method for reducing the amount of migrateables of polymer coatings |
-
1999
- 1999-06-17 JP JP20806399A patent/JP3512355B2/en not_active Expired - Lifetime
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9737637B2 (en) | 2004-11-29 | 2017-08-22 | Dsm Ip Assets B.V. | Method for reducing the amount of migrateables of polymer coatings |
| JP2009518479A (en) * | 2005-12-09 | 2009-05-07 | ディーエスエム アイピー アセッツ ビー.ブイ. | Hydrophilic coating containing polyelectrolyte |
| JP2013079382A (en) * | 2005-12-09 | 2013-05-02 | Dsm Ip Assets Bv | Hydrophilic coating comprising polyelectrolyte |
| US8512795B2 (en) | 2005-12-09 | 2013-08-20 | Dsm Ip Assets B.V. | Hydrophilic coating comprising a polyelectrolyte |
| US8871869B2 (en) | 2005-12-09 | 2014-10-28 | Dsm Ip Assets B.V. | Hydrophilic coating |
| US8828546B2 (en) | 2006-09-13 | 2014-09-09 | Dsm Ip Assets B.V. | Coated medical device |
| US8513320B2 (en) | 2007-02-28 | 2013-08-20 | Dsm Ip Assets B.V. | Hydrophilic coating |
| US8809411B2 (en) | 2007-02-28 | 2014-08-19 | Dsm Ip Assets B.V. | Hydrophilic coating |
| US8957125B2 (en) | 2010-06-16 | 2015-02-17 | Dsm Ip Assets B.V. | Coating formulation for preparing a hydrophilic coating |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3512355B2 (en) | 2004-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6340465B1 (en) | Lubricious coatings for medical devices | |
| EP2982390B1 (en) | Medical device and method for manufacturing medical device | |
| US7419709B2 (en) | Polymer coating for medical devices | |
| EP2519270B1 (en) | Silyl ether-modified hydrophilic polymers and uses for medical articles | |
| EP1667747B1 (en) | Lubricious coatings for medical device | |
| JP2003510134A (en) | Coating with hydrophilic lubricant for medical devices | |
| JP2012509365A (en) | Surface modification of polymers with surface active and reactive end groups | |
| JP2001509052A (en) | Tie layer for medical device surface coating | |
| JP2001500407A (en) | Process for producing polyurethane grafted with polyethylene oxide having covalently bound heparin | |
| JPH07100744B2 (en) | Medical device having surface lubricity when wet and method for producing the same | |
| AU2002329402B2 (en) | Treating surfaces to enhance bio-compatibility | |
| JP3512355B2 (en) | Medical device with lubricity | |
| JPH0412145B2 (en) | ||
| AU2002329402A1 (en) | Treating surfaces to enhance bio-compatibility | |
| JP3776194B2 (en) | Medical device and method for manufacturing the same | |
| JPH05184666A (en) | Guide wire and its manufacture | |
| JPH0819599A (en) | Medical device having lubricative surface upon wetting and manufacture thereof | |
| JP4143883B2 (en) | Medical device and manufacturing method thereof | |
| CN107929819B (en) | Medical metal surface hydrophilic coating and preparation method thereof | |
| JP4143894B2 (en) | Medical device and manufacturing method thereof | |
| JP3331571B2 (en) | Medical device and manufacturing method thereof | |
| EP3053975B1 (en) | Coating layer, coating solution, method for forming coating layer, and method for producing medical tool | |
| JP3336601B2 (en) | Medical device and manufacturing method thereof | |
| JP2024545725A (en) | Composition for surface treatment of polymeric materials, kit and surface treatment method | |
| JP2003225300A (en) | Medical device and manufacturing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TRDD | Decision of grant or rejection written | ||
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040106 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 3512355 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090116 Year of fee payment: 5 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100116 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100116 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110116 Year of fee payment: 7 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120116 Year of fee payment: 8 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120116 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130116 Year of fee payment: 9 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140116 Year of fee payment: 10 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |